Can multi-metal burden contribute to cognitive decline?

Multi-metal exposure is relevant to cognitive health because combined exposures are associated with systemic oxidative and inflammatory stress, and prospective data link higher mixture burden with poorer cognition and dementia risk. In an older adult, these pathways may be especially pertinent, although they do not establish that metals are the cause of an individual’s cognitive symptoms.

Clinical and human evidence

• Human biomonitoring studies link metal mixtures to oxidative injury: in 768 adults, a 25% increase in urinary-metal mixture exposure corresponded to 77.6% higher urinary 8-OHdG, a marker of oxidative DNA damage. Other cohorts found associations with GSSG/GSH, malondialdehyde, and 8-oxo-dG.
• Mixtures of cadmium, lead, mercury, and other metals have been associated with higher C-reactive protein, systemic immune-inflammation indices, and in some studies TNF-α; associations are nonlinear and depend on the constituent metals.
• Most importantly, the prospective MESA cohort found that a higher urinary nine-metal mixture was associated with poorer cognitive performance and higher incident dementia risk (95th vs 25th percentile HR 1.71).

Mechanistic evidence

• Metals can converge on glutathione depletion, reactive oxygen species generation, lipid/DNA damage, impaired electron transport, loss of mitochondrial membrane potential, reduced ATP production, and permeability-transition-pore opening. Direct evidence that realistic mixtures produce greater-than-additive mitochondrial injury remains limited.
• Experimental mixed-metal models show microglial activation and inflammatory signaling. In a 2024 mouse model, manganese and lead acted with aluminum through CCR5 and TLR4–NF-κB pathways, with blood–brain-barrier disruption and neuroinflammation.
• Neuroinflammation is clinically relevant: higher CSF YKL-40, ICAM-1, VCAM-1, IL-15, Flt-1, and CCL2, as well as microglial-PET signal, predict faster decline in AD/MCI cohorts.

Bottom line

• A multi-metal burden can plausibly contribute to cognitive-risk biology through oxidative stress, systemic immune activation, mitochondrial injury, and neuroinflammation; direct human evidence supports oxidative/inflammatory associations and an association with dementia risk, while CNS and mitochondrial mediation remain less directly established.